Literature DB >> 12920299

SCNM1, a putative RNA splicing factor that modifies disease severity in mice.

David A Buchner1, Michelle Trudeau, Miriam H Meisler.   

Abstract

The severity of many inherited disorders is influenced by genetic background. We describe a modifier interaction in C57BL/6Jmice that converts a chronic movement disorder into a lethal neurological disease. The primary mutation (medJ) changes a splice donor site of the sodium channel gene Scn8a (Nav1.6). The modifier mutation is characteristic of strain C57BL/6Jand introduces a nonsense codon into sodium channel modifier 1 (SCNM1), a zinc finger protein and a putative splice factor. An internally deleted SCNM1 protein is also predicted as a result of exon skipping associated with disruption of a consensus exonic splicing enhancer. The effect of the modifier mutation is to reduce the abundance of correctly spliced sodium channel transcripts below the threshold for survival. Our finding that genetic variation in a putative RNA splicing factor influences disease susceptibility in mice raises the possibility that a similar mechanism modifies the severity of human inherited disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920299     DOI: 10.1126/science.1086187

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  49 in total

Review 1.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

2.  Alternative splicing induced by nonsense mutations in the immunoglobulin mu VDJ exon is independent of truncation of the open reading frame.

Authors:  Marc Bühler; Oliver Mühlemann
Journal:  RNA       Date:  2004-12-21       Impact factor: 4.942

3.  Nonsense-associated alternative splicing of T-cell receptor beta genes: no evidence for frame dependence.

Authors:  Fabio Mohn; Marc Bühler; Oliver Mühlemann
Journal:  RNA       Date:  2004-12-21       Impact factor: 4.942

4.  Determinants of the inherent strength of human 5' splice sites.

Authors:  Xavier Roca; Ravi Sachidanandam; Adrian R Krainer
Journal:  RNA       Date:  2005-05       Impact factor: 4.942

Review 5.  Sodium channel mutations in epilepsy and other neurological disorders.

Authors:  Miriam H Meisler; Jennifer A Kearney
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

6.  Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.

Authors:  Robert C Wilson; Saroj Nimkarn; Miro Dumic; Jihad Obeid; Maryam Razzaghy Azar; Maryam Azar; Hossein Najmabadi; Fatemeh Saffari; Maria I New
Journal:  Mol Genet Metab       Date:  2007-02-01       Impact factor: 4.797

7.  Enhanced VWF biosynthesis and elevated plasma VWF due to a natural variant in the murine Vwf gene.

Authors:  Heidi L Lemmerhirt; Jordan A Shavit; Gallia G Levy; Suzanne M Cole; Jeffrey C Long; David Ginsburg
Journal:  Blood       Date:  2006-07-27       Impact factor: 22.113

8.  Modifier genes and non-genetic factors reshape anatomical deficits in Zfp423-deficient mice.

Authors:  Wendy A Alcaraz; Edward Chen; Phoebe Valdes; Eunnie Kim; Yuan Hung Lo; Jennifer Vo; Bruce A Hamilton
Journal:  Hum Mol Genet       Date:  2011-07-05       Impact factor: 6.150

9.  Bringing genetic background into focus.

Authors:  Clement Y Chow
Journal:  Nat Rev Genet       Date:  2015-12-14       Impact factor: 53.242

10.  Fine mapping of an epilepsy modifier gene on mouse Chromosome 19.

Authors:  Sarah K Bergren; Elizabeth D Rutter; Jennifer A Kearney
Journal:  Mamm Genome       Date:  2009-06-10       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.